| scholarly article | Q13442814 |
| P50 | author | Nayoun Kim | Q86299328 |
| Seok-Goo Cho | Q44434942 | ||
| P2093 | author name string | Eun-Sol Lee | |
| Jung-Yeon Lim | |||
| Keon-Il Im | |||
| Young-Sun Nam | |||
| P2860 | cites work | Targeting improves MSC treatment of inflammatory bowel disease | Q24601626 |
| Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis | Q24612869 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Adult bone marrow stromal cells differentiate into neural cells in vitro | Q28142055 | ||
| TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis | Q84595209 | ||
| Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model | Q86245224 | ||
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis | Q33769303 | ||
| Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance | Q34231351 | ||
| IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease | Q34491107 | ||
| The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection | Q34936487 | ||
| Aire controls mesenchymal stem cell-mediated suppression in chronic colitis | Q35665164 | ||
| The genetics and immunopathogenesis of inflammatory bowel disease | Q37171800 | ||
| Mesenchymal Stem Cells: Mechanisms of Inflammation | Q37809081 | ||
| The immunomodulatory properties of mesenchymal stem cells | Q37866167 | ||
| The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. | Q38073107 | ||
| Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. | Q38110707 | ||
| Clinical applications of mesenchymal stem cells | Q38122364 | ||
| Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation | Q38469488 | ||
| Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis | Q40727194 | ||
| The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population | Q42069051 | ||
| Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial | Q42672137 | ||
| Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study | Q43526778 | ||
| Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis | Q43985688 | ||
| Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula | Q44012199 | ||
| Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. | Q45834735 | ||
| Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells | Q45844247 | ||
| Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
| Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. | Q51474101 | ||
| Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. | Q51775892 | ||
| Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa. | Q53154622 | ||
| Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. | Q53476120 | ||
| Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. | Q53532396 | ||
| Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. | Q54302606 | ||
| Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells | Q59102107 | ||
| A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation | Q59395439 | ||
| Ultrastructure of L-phase variants isolated from a culture of Mycobacterium phlei | Q67316554 | ||
| Haemopoietic stem cells and the problem of self-renewal | Q70803381 | ||
| Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell | Q81491656 | ||
| Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6 | Q82209428 | ||
| Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas | Q82416832 | ||
| Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis | Q83172279 | ||
| Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease | Q83272771 | ||
| Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis | Q83319968 | ||
| Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells | Q83586509 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 2030-2039 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis | |
| P478 | volume | 21 |
| Q46689376 | Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery |
| Q55048256 | Comparative Study on In Vitro Culture of Mouse Bone Marrow Mesenchymal Stem Cells. |
| Q41042265 | Jianpi Qingchang decoction regulates intestinal motility of dextran sulfate sodium-induced colitis through reducing autophagy of interstitial cells of Cajal |
| Q37677012 | Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage |
| Q91695791 | Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review |
| Q92827314 | Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies |
| Q28077427 | Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology |
| Q35653672 | New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation |
| Q58788690 | Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation |
| Q37406435 | Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
Search more.